tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

KALA Stock Latest News

Kala Pharmaceuticals assumed with an Outperform at Oppenheimer
The FlyKala Pharmaceuticals assumed with an Outperform at Oppenheimer
28d ago
KALA
Kala Pharmaceuticals price target lowered to $12 from $15 at H.C. Wainwright
PremiumThe Fly
Kala Pharmaceuticals price target lowered to $12 from $15 at H.C. Wainwright
1M ago
KALA
Kala Pharmaceuticals Advances KPI-012 in Clinical Trials
PremiumCompany Announcements
Kala Pharmaceuticals Advances KPI-012 in Clinical Trials
1M ago
KALA
Kala Pharmaceuticals reports Q1 EPS ($1.41) vs ($4.20) last year
PremiumThe Fly
Kala Pharmaceuticals reports Q1 EPS ($1.41) vs ($4.20) last year
2M ago
KALA
Kala Pharmaceuticals Announces Executive Retention Agreements
PremiumCompany Announcements
Kala Pharmaceuticals Announces Executive Retention Agreements
3M ago
8K
KALA
Kala Pharmaceuticals: Promising Clinical Developments and Financial Stability Support Buy Rating
PremiumRatingsKala Pharmaceuticals: Promising Clinical Developments and Financial Stability Support Buy Rating
3M ago
KALA
Kala Pharmaceuticals management to meet with Oppenheimer
Premium
The Fly
Kala Pharmaceuticals management to meet with Oppenheimer
3M ago
KALA
KALA BIO Advances Eye Disease Therapies with New Funding
Premium
Company Announcements
KALA BIO Advances Eye Disease Therapies with New Funding
3M ago
KALA
Kala Pharmaceuticals reports Q4 EPS ($1.74) vs. ($3.18) last year
PremiumThe Fly
Kala Pharmaceuticals reports Q4 EPS ($1.74) vs. ($3.18) last year
3M ago
KALA
Kala Pharmaceuticals sees cash runway into 1Q26
PremiumThe Fly
Kala Pharmaceuticals sees cash runway into 1Q26
3M ago
KALA
KALA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
KALA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
KALA
Kala announces resignation of CEO Iwicki, Bazemore appointed interim CEO
PremiumThe Fly
Kala announces resignation of CEO Iwicki, Bazemore appointed interim CEO
5M ago
KALA
Kala Pharmaceuticals files to sell 1.67M shares of common stock for holders
PremiumThe FlyKala Pharmaceuticals files to sell 1.67M shares of common stock for holders
5M ago
KALA
Kala Bio to sell 1.34M shares at $6.44 in private placement
Premium
The Fly
Kala Bio to sell 1.34M shares at $6.44 in private placement
6M ago
KALA
Kala Bio Advances PCED Treatment Amid Financial Update
Premium
Company Announcements
Kala Bio Advances PCED Treatment Amid Financial Update
8M ago
KALA
Kala Pharmaceuticals reports Q3 EPS ($1.93) vs ($3.41) last year
PremiumThe Fly
Kala Pharmaceuticals reports Q3 EPS ($1.93) vs ($3.41) last year
8M ago
KALA
Kala Pharmaceuticals Board Member Mark Blumenkranz Resigns
PremiumCompany Announcements
Kala Pharmaceuticals Board Member Mark Blumenkranz Resigns
9M ago
8K
KALA
Oppenheimer ‘encouraged’ by Kala Pharmaceuticals trial progress
PremiumThe Fly
Oppenheimer ‘encouraged’ by Kala Pharmaceuticals trial progress
10M ago
KALA
Kala Pharmaceuticals price target lowered to $15 from $18 at H.C. Wainwright
PremiumThe Fly
Kala Pharmaceuticals price target lowered to $15 from $18 at H.C. Wainwright
11M ago
KALA
Kala Pharmaceuticals reports Q2 EPS ($3.16) vs ($4.36) last year
PremiumThe FlyKala Pharmaceuticals reports Q2 EPS ($3.16) vs ($4.36) last year
11M ago
KALA
Kala Pharmaceuticals files to sell 3.52M shares of common stock for holders
Premium
The Fly
Kala Pharmaceuticals files to sell 3.52M shares of common stock for holders
11M ago
KALA
Kala Pharmaceuticals to sell 1.197M shares at $5.85 in private placement
Premium
The Fly
Kala Pharmaceuticals to sell 1.197M shares at $5.85 in private placement
1y ago
KALA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >